Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Russian pharma strategy cheers domestic firms but is criticised by state purse-keeper

This article was originally published in RAJ Devices

Executive Summary

The Russian ministry for economy and energy has finalised the draft: “Strategy for the development of the pharmaceutical industry in the Russian Federation until 2020”, on which it has been working since the beginning of this year. The draft – presently being discussed by the country’s cabinet – has already been criticised by the ministry of finance, raising fears among domestic drug manufacturers that the Russian pharmaceutical industry will not see any significant results from the document’s implementation.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts